Pipeline >> Clinical Trials

»

Synergy Clinical Trials

Next three clinical trials underway or planned for Plecanatide in CIC and IBS-C




UNDERWAY (BEGAN 4Q 2011)

  1. •Phase IIb/III, 12 week dose-ranging, placebo-controlled trial in CIC patients (N~800)

  2. -Key proof-of-concept (POC) trial - powered for statistical significance

  3. •Phase II, 8 week, placebo-controlled, dose ranging trial in IBS-C (N~320)



PLANNED

  1. •Phase III, 12 week, placebo-controlled trial in CIC (N~900)



The CIC Study


For information about the CIC study, please see http://www.cicstudy.com

For ongoing and completed trials see descriptions at www.clinicaltrials.gov

 
About Us
PipelineAbout_Synergy_Pharmaceuticals.htmlshapeimage_9_link_0
PartneringPipeline_Overview.htmlshapeimage_10_link_0
Investor RelationsPartnering.htmlshapeimage_11_link_0
NewsInvestor_Relations_Information.htmlshapeimage_12_link_0
Contact UsSynergy_News_Summary.htmlshapeimage_13_link_0
Contact UsContact_Us.htmlshapeimage_14_link_0
Pipeline Overview
SP-304Pipeline_Overview.htmlshapeimage_16_link_0
SP-333Plecanatide_SP-304.htmlPlecanatide_SP-304.htmlshapeimage_17_link_0shapeimage_17_link_1
Synergy Clinical TrialsSP-333.htmlshapeimage_18_link_0
Basic Scienceshapeimage_19_link_0
MarketsBasic_Science.htmlshapeimage_20_link_0
Publications & PresentationsMarkets.htmlshapeimage_21_link_0
Publications & PresentationsPublications_Presentations.htmlshapeimage_22_link_0
Copyright 2010 © Synergy Pharmaceuticals, Inc., 420 Lexington Avenue, Suite 1609, New York, NY 10170, USALegal.htmlContact_Us.htmlshapeimage_24_link_0shapeimage_24_link_1
Copyright 2010 © Synergy Pharmaceuticals, Inc., 420 Lexington Avenue, Suite 1609, New York, NY 10170, USA